Lee Moss
Impact in
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
-
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 5
- Antifungal resistance and susceptibility 1
- HIV/AIDS Research and Interventions 1
-
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- David S. Wagner (3 shared papers)William R. Spreen (2 shared papers)Susan L. Ford (2 shared papers)Yu Lou (3 shared papers)Stephen C. Piscitelli (2 shared papers)Zhi Hong (1 shared paper)Kasi Russell‐Lodrigue (1 shared paper)Martin H. Markowitz (1 shared paper)
- Journals
- Xenobiotica (3 papers)Antimicrobial Agents and Chemotherapy (1 paper)Science (1 paper)Medical Mycology (1 paper)Clinical Pharmacology in Drug Development (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Lee Moss
7 papers receiving 333 citations
Peers
Comparison fields: 5 of 42
- Infectious Diseases 252
- Virology 29
- Pharmaceutical Science 38
- Pharmacology 33
- Biomaterials 18
Countries citing papers authored by Lee Moss
This map shows the geographic impact of Lee Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Moss more than expected).
Fields of papers citing papers by Lee Moss
This network shows the impact of papers produced by Lee Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Moss. The network helps show where Lee Moss may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Moss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 140 | |
| 2 | 2013 | 123 | |
| 3 | 2015 | 47 | |
| 4 | 2014 | 24 | |
| 5 | 1993 | 7 | |
| 6 | 2010 | 7 | |
| 7 | 2014 | 3 |
About Lee Moss
Lee Moss is a scholar working on Infectious Diseases, Pharmacology, Virology, Hepatology and Nuclear Energy and Engineering, having authored 7 papers that have together received 351 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Pharmacogenetics and Drug Metabolism (2 papers), Antifungal resistance and susceptibility (1 paper), HIV/AIDS Research and Interventions (1 paper), HIV Research and Treatment (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Infectious Diseases (252 citations), Virology (29 citations), Pharmaceutical Science (38 citations), Pharmacology (33 citations) and Biomaterials (18 citations). Lee Moss has collaborated with scholars based in United States and Japan. Frequent co-authors include David S. Wagner, William R. Spreen, Susan L. Ford, Yu Lou, Stephen C. Piscitelli, Zhi Hong, Kasi Russell‐Lodrigue, Martin H. Markowitz, Hiroshi Mohri and Rudolf P. Bohm. Their work appears in journals such as Xenobiotica, Antimicrobial Agents and Chemotherapy, Science, Medical Mycology and Clinical Pharmacology in Drug Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.